These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 703522)

  • 21. Proteomic analysis of changes in the protein composition of MCF-7 human breast cancer cells induced by all-trans retinoic acid, 9-cis retinoic acid, and their combination.
    Flodrova D; Benkovska D; Macejova D; Bialesova L; Hunakova L; Brtko J; Bobalova J
    Toxicol Lett; 2015 Jan; 232(1):226-32. PubMed ID: 25455455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-lactalbumin production in human mammary carcinoma.
    Rose HN; McGrath CM
    Science; 1975 Nov; 190(4215):673-5. PubMed ID: 1188362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine A inhibition of prolactin-dependent up-regulation of BRCA1 protein expression in human breast cell lines.
    Favy DA; Rio PG; Vissac C; Maurizis JC; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2000; 20(3A):1703-4. PubMed ID: 10928095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha
    Castillo LF; Rivero EM; Goffin V; Lüthy IA
    Cell Signal; 2017 Jun; 34():76-85. PubMed ID: 28302567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen regulation of growth and specific protein synthesis in human breast cancer cells in tissue culture.
    Edwards DP; Adams DJ; McGuire WL
    Adv Exp Med Biol; 1981; 138():133-49. PubMed ID: 7342712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism by which prolactin regulates protein, RNA, and DNA synthesis in Nb2 node lymphoma cells.
    Rillema JA; Tarrant TM; Linebaugh BE
    Biochim Biophys Acta; 1989 Oct; 1014(1):78-82. PubMed ID: 2553110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Res; 1976 Dec; 36(12):4610-8. PubMed ID: 1000506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of prolactin binding by cyclosporine A on MCF7 breast tumour cell line.
    Bernard DJ; Maurizis JC; Sauvezie B; Bignon YJ; Chassagne J; Chollet P; Plagne R
    Anticancer Res; 1991; 11(6):2147-51. PubMed ID: 1776854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin receptors in human breast cancer cells in long-term tissue culture.
    Shiu RP
    Cancer Res; 1979 Nov; 39(11):4381-6. PubMed ID: 227585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7.
    Nunez AM; Jakowlev S; Briand JP; Gaire M; Krust A; Rio MC; Chambon P
    Endocrinology; 1987 Nov; 121(5):1759-65. PubMed ID: 3665845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of iodide uptake and sodium/iodide symporter expression in the mcf-7 human breast cancer cell line.
    Arturi F; Ferretti E; Presta I; Mattei T; Scipioni A; Scarpelli D; Bruno R; Lacroix L; Tosi E; Gulino A; Russo D; Filetti S
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2321-6. PubMed ID: 15623812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
    Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
    Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen.
    Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC
    Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin homogeneously induces the tRNA population of mouse mammary explants.
    Green MR; Hatfield DL; Miller MJ; Peacock AC
    Biochem Biophys Res Commun; 1985 May; 129(1):233-9. PubMed ID: 4004876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Lactalbumin in human and subhuman primate normal mammary tissue and in human breast cancer as a marker for prolactin activity.
    Kleinberg DL; Todd J
    Cancer Res; 1978 Nov; 38(11 Pt 2):4318-22. PubMed ID: 100218
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.
    Langenheim JF; Chen WY
    Breast Cancer Res Treat; 2005 Apr; 90(3):281-93. PubMed ID: 15830142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.
    Vignon F; Capony F; Chambon M; Freiss G; Garcia M; Rochefort H
    Endocrinology; 1986 Apr; 118(4):1537-45. PubMed ID: 3948791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells.
    Philips N; McFadden K
    Cancer Lett; 2004 Mar; 206(1):63-8. PubMed ID: 15019161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.